Amy Feldman
@amyfeldman7.bsky.social
Forbes senior editor covering healthcare. Email [email protected], signal amyfeldman.33
Pinned
GLP-1s Took Eli Lilly To $1 Trillion. CEO Dave Ricks Is Betting Billions He Can Do It Again
CEO Dave Ricks built Eli Lilly into the first $1 trillion pharma company with its blockbuster weight-loss and diabetes drugs. But with more than 60% of revenue coming from them, the drug giant faces t...
www.forbes.com
*NEW* Eli Lilly became the 1st trillion-dollar pharma company off GLP-1s. But with >60% of revenue coming from one molecule, it needs a next act. I went to Indianapolis to talk to CEO Dave Ricks & team about acquisitions, R&D and preventive health
@forbes.com
www.forbes.com/sites/amyfel...
@forbes.com
www.forbes.com/sites/amyfel...
*NEW* Colossal Biosciences’ Ben Lamm and Anduril’s Palmer Luckey team up on a new startup to genetically engineer war dogs for the military. Warhound comes out of stealth at $1.2B valuation
For @forbes.com with @iainmartin.bsky.social and @mhunterhart.bsky.social
www.forbes.com/sites/amyfel...
For @forbes.com with @iainmartin.bsky.social and @mhunterhart.bsky.social
www.forbes.com/sites/amyfel...
Billionaires Palmer Luckey And Ben Lamm Spin Up Startup To Genetically Engineer Military Dogs
Ben Lamm of de-extinction startup Colossal has teamed up with Palmer Luckey’s team at Anduril to create a dog that’s optimized for military use. The new “warhounds” will be cloned and gene edited.
www.forbes.com
October 22, 2026 at 11:09 PM
*NEW* Colossal Biosciences’ Ben Lamm and Anduril’s Palmer Luckey team up on a new startup to genetically engineer war dogs for the military. Warhound comes out of stealth at $1.2B valuation
For @forbes.com with @iainmartin.bsky.social and @mhunterhart.bsky.social
www.forbes.com/sites/amyfel...
For @forbes.com with @iainmartin.bsky.social and @mhunterhart.bsky.social
www.forbes.com/sites/amyfel...
What if we could avoid hip and knee surgeries in the future with a pill?
*NEW* @forbes.com
www.forbes.com/sites/innova...
*NEW* @forbes.com
www.forbes.com/sites/innova...
Like A ‘GLP-1’ For Muscles And Cartilage?
Researchers Regrew Knee Cartilage In Mice. Now A Biotech Is Doing Clinical Trials.
www.forbes.com
October 21, 2026 at 2:20 PM
What if we could avoid hip and knee surgeries in the future with a pill?
*NEW* @forbes.com
www.forbes.com/sites/innova...
*NEW* @forbes.com
www.forbes.com/sites/innova...
Would you pay $5,000 to preserve your immune cells? New for @forbes.com on a new service from biotech Cellino that does just that
www.forbes.com/sites/amyfel...
www.forbes.com/sites/amyfel...
You Can Now Preserve Your Immune Cells For $5,000 In Case They’re Helpful In The Future
Your immune cells are constantly aging. Cellino is launching a new service, called Reservoir, to let people securely store them from a simple blood draw for $5,000.
www.forbes.com
October 15, 2026 at 1:06 PM
Would you pay $5,000 to preserve your immune cells? New for @forbes.com on a new service from biotech Cellino that does just that
www.forbes.com/sites/amyfel...
www.forbes.com/sites/amyfel...
*NEW* Eli Lilly became the 1st trillion-dollar pharma company off GLP-1s. But with >60% of revenue coming from one molecule, it needs a next act. I went to Indianapolis to talk to CEO Dave Ricks & team about acquisitions, R&D and preventive health
@forbes.com
www.forbes.com/sites/amyfel...
@forbes.com
www.forbes.com/sites/amyfel...
GLP-1s Took Eli Lilly To $1 Trillion. CEO Dave Ricks Is Betting Billions He Can Do It Again
CEO Dave Ricks built Eli Lilly into the first $1 trillion pharma company with its blockbuster weight-loss and diabetes drugs. But with more than 60% of revenue coming from them, the drug giant faces t...
www.forbes.com
October 15, 2026 at 12:57 PM
*NEW* Eli Lilly became the 1st trillion-dollar pharma company off GLP-1s. But with >60% of revenue coming from one molecule, it needs a next act. I went to Indianapolis to talk to CEO Dave Ricks & team about acquisitions, R&D and preventive health
@forbes.com
www.forbes.com/sites/amyfel...
@forbes.com
www.forbes.com/sites/amyfel...
A bumper crop of biotech IPOs, more than 2 dozen this year including two more this week. New for @forbes.com
www.forbes.com/sites/innova...
www.forbes.com/sites/innova...
2026 Has Been A Bumper Year For Biotech IPOs
In this week’s edition of InnovationRx, the bumper crop of biotech IPOs, Isomorphic’s reported $40 billion valuation fundraise, and the impact of drugmakers’ gifts to doctors.
www.forbes.com
October 14, 2026 at 1:24 PM
A bumper crop of biotech IPOs, more than 2 dozen this year including two more this week. New for @forbes.com
www.forbes.com/sites/innova...
www.forbes.com/sites/innova...
The world’s richest person spent — $276M — on Republican candidates in the midterms 💰
www.nytimes.com/2026/10/12/u...
www.nytimes.com/2026/10/12/u...
Inside Elon Musk’s $276 Million Midterm Rescue Mission for Republicans
The world’s richest person has quietly become by far the biggest known midterm donor, trying to save Republicans’ Senate majority with some of the largest donations in American political history.
www.nytimes.com
October 12, 2026 at 1:15 PM
The world’s richest person spent — $276M — on Republican candidates in the midterms 💰
www.nytimes.com/2026/10/12/u...
www.nytimes.com/2026/10/12/u...
Reposted by Amy Feldman
As Medicare open enrollment begins this month, roughly 5 million people may be forced to switch plans, often paying much more, because their current policy has been canceled or is no longer offered where they live. 🎁
www.nytimes.com/2026/10/09/b...
www.nytimes.com/2026/10/09/b...
Private Medicare Plans Are Raising Costs And Forcing Millions To Find New Insurance (Gift Article)
As enrollment for Medicare Advantage begins this month, older Americans are confronting fewer options because insurers are discontinuing coverage in many areas.
www.nytimes.com
October 9, 2026 at 9:33 PM
As Medicare open enrollment begins this month, roughly 5 million people may be forced to switch plans, often paying much more, because their current policy has been canceled or is no longer offered where they live. 🎁
www.nytimes.com/2026/10/09/b...
www.nytimes.com/2026/10/09/b...
Reposted by Amy Feldman
NEW: Last fall, executives at TikTok slashed the number of violations for which a TikTok advertiser could be immediately banned by more than half, per policy documents and four TikTok sources. That opened the floodgates to a surge in scams. with @iainmartin.bsky.social www.forbes.com/sites/iainma...
October 7, 2026 at 4:16 PM
NEW: Last fall, executives at TikTok slashed the number of violations for which a TikTok advertiser could be immediately banned by more than half, per policy documents and four TikTok sources. That opened the floodgates to a surge in scams. with @iainmartin.bsky.social www.forbes.com/sites/iainma...
Depressing
another year where all the science nobels went to men, as was the case in 2024
much of this piece, about the structural barriers women face in doing innovative research and receiving credit for it, holds up (I think)
www.statnews.com/2024/10/11/n...
much of this piece, about the structural barriers women face in doing innovative research and receiving credit for it, holds up (I think)
www.statnews.com/2024/10/11/n...
Men won all the science Nobels this year. There's an even bigger problem
The Nobel's gender gap reflects larger barriers faced by women in science
www.statnews.com
October 7, 2026 at 2:24 PM
Depressing
The first startup to spin out of Jennifer Doudna’s lab in 2011, Caribou Biosciences, halts its pipeline, lays off staff and looks for “potential paths forward for the company and its assets” as funding dries up
www.fiercebiotech.com/biotech/cari...
www.fiercebiotech.com/biotech/cari...
CAR-T biotech Caribou makes ‘heartbreaking’ call to shrink headcount, halt pipeline
Caribou Biosciences, the off-the-shelf cell therapy outfit that spun out of Nobel Laureate Jennifer Doudna’s lab in 2011, is
www.fiercebiotech.com
October 7, 2026 at 2:23 PM
The first startup to spin out of Jennifer Doudna’s lab in 2011, Caribou Biosciences, halts its pipeline, lays off staff and looks for “potential paths forward for the company and its assets” as funding dries up
www.fiercebiotech.com/biotech/cari...
www.fiercebiotech.com/biotech/cari...
In this week’s @forbes.com health newsletter, I report on how Cleveland Clinic + startup Piramidal are developing AI to help detect brain seizures. Plus a former OpenAI exec’s plan to treat complex chronic disease + Ramaswamy’s est $12M tax cut from moving to Ohio
www.forbes.com/sites/innova...
www.forbes.com/sites/innova...
How Cleveland Clinic Is Developing AI To Monitor The Brain
In this week’s edition of InnovationRx, we look at Cleveland Clinic’s AI for brain seizures, Fidji Simo’s plan to solve complex, chronic disease, and Vivek Ramaswamy’s estimated $12 million tax cut.
www.forbes.com
October 7, 2026 at 1:20 PM
In this week’s @forbes.com health newsletter, I report on how Cleveland Clinic + startup Piramidal are developing AI to help detect brain seizures. Plus a former OpenAI exec’s plan to treat complex chronic disease + Ramaswamy’s est $12M tax cut from moving to Ohio
www.forbes.com/sites/innova...
www.forbes.com/sites/innova...
Former OpenAI exec Fidji Simo started ChronicleBio to find treatments for complex chronic conditions (including her own POTS) using AI and lots of biological data. So far it has ID’d 13 diff subtypes of illnesses, + plans a 1st clinical trial this year.
@forbes.com
www.forbes.com/sites/amyfel...
@forbes.com
www.forbes.com/sites/amyfel...
Former OpenAI Exec Fidji Simo’s $20 Million Plan To Solve Her Chronic Disease And Others
Sufferers of complex, chronic diseases like POTS and long COVID often spend years searching for relief. The longtime tech exec started ChronicleBio to find treatments using AI and lots of biological d...
www.forbes.com
October 1, 2026 at 2:14 PM
Former OpenAI exec Fidji Simo started ChronicleBio to find treatments for complex chronic conditions (including her own POTS) using AI and lots of biological data. So far it has ID’d 13 diff subtypes of illnesses, + plans a 1st clinical trial this year.
@forbes.com
www.forbes.com/sites/amyfel...
@forbes.com
www.forbes.com/sites/amyfel...
And way before that the Boom Boom Room
But I really believed then that things would change for the next generation of women
www.cnn.com/2021/05/27/p...
But I really believed then that things would change for the next generation of women
www.cnn.com/2021/05/27/p...
September 27, 2026 at 6:28 PM
And way before that the Boom Boom Room
But I really believed then that things would change for the next generation of women
www.cnn.com/2021/05/27/p...
But I really believed then that things would change for the next generation of women
www.cnn.com/2021/05/27/p...
When the Weed Wars Came to Warren Street
New money and age-old injustice in an American river town.
www.nytimes.com
September 27, 2026 at 3:05 PM
AI Is Supercharging Stock Scams
Plus, the bond panic subsides.
www.wsj.com
September 25, 2026 at 4:51 PM
Peptides like “tesa” and sermorelin are landing fitness fans in the hospital with allergic reactions.
*NEW* from @iainmartin.bsky.social and me for @forbes.com
www.forbes.com/sites/iainma...
*NEW* from @iainmartin.bsky.social and me for @forbes.com
www.forbes.com/sites/iainma...
Peptides Like ‘Tesa’ And Sermorelin Are Landing Fitness Fans In The Hospital With Allergic Reactions
A class of peptides that are meant to stimulate human growth hormone has been linked with a spat of severe allergic reactions and anaphylactic shock-like symptoms.
www.forbes.com
September 25, 2026 at 1:30 PM
Peptides like “tesa” and sermorelin are landing fitness fans in the hospital with allergic reactions.
*NEW* from @iainmartin.bsky.social and me for @forbes.com
www.forbes.com/sites/iainma...
*NEW* from @iainmartin.bsky.social and me for @forbes.com
www.forbes.com/sites/iainma...
Alice Walton on why she’s funding a big new Arkansas hospital, the biotech billionaire versus the physician in the Ohio governor’s race and more in this week’s @forbes.com InnovationRx newsletter
www.forbes.com/sites/innova...
www.forbes.com/sites/innova...
Alice Walton On Her Plans For A Major New Arkansas Hospital
Alice Walton talks about why she's funding a major new Arkansas hospital in this week's Forbes innovationRx newsletter.
www.forbes.com
September 23, 2026 at 5:10 PM
Alice Walton on why she’s funding a big new Arkansas hospital, the biotech billionaire versus the physician in the Ohio governor’s race and more in this week’s @forbes.com InnovationRx newsletter
www.forbes.com/sites/innova...
www.forbes.com/sites/innova...
Reposted by Amy Feldman
Memorial Sloan Kettering is opening up its voluminous data on genetic variants of cancer and their treatments with OpenEvidence
And OE also plans to use the data to develop a pipeline of therapies starting with a focus on rare cancers
NEW for @forbes.com
www.forbes.com/sites/innova...
And OE also plans to use the data to develop a pipeline of therapies starting with a focus on rare cancers
NEW for @forbes.com
www.forbes.com/sites/innova...
A Premier Cancer Hospital Makes Its Data Available To Doctors Nationwide Through OpenEvidence
Memorial Sloan Kettering opens up its cancer data through OpenEvidence. Which healthcare and biotech entrepreneurs made the Forbes 400 for the first time. Persistent generic cancer drug shortages. The...
www.forbes.com
September 16, 2026 at 4:19 PM
Memorial Sloan Kettering is opening up its voluminous data on genetic variants of cancer and their treatments with OpenEvidence
And OE also plans to use the data to develop a pipeline of therapies starting with a focus on rare cancers
NEW for @forbes.com
www.forbes.com/sites/innova...
And OE also plans to use the data to develop a pipeline of therapies starting with a focus on rare cancers
NEW for @forbes.com
www.forbes.com/sites/innova...
Memorial Sloan Kettering is opening up its voluminous data on genetic variants of cancer and their treatments with OpenEvidence
And OE also plans to use the data to develop a pipeline of therapies starting with a focus on rare cancers
NEW for @forbes.com
www.forbes.com/sites/innova...
And OE also plans to use the data to develop a pipeline of therapies starting with a focus on rare cancers
NEW for @forbes.com
www.forbes.com/sites/innova...
A Premier Cancer Hospital Makes Its Data Available To Doctors Nationwide Through OpenEvidence
Memorial Sloan Kettering opens up its cancer data through OpenEvidence. Which healthcare and biotech entrepreneurs made the Forbes 400 for the first time. Persistent generic cancer drug shortages. The...
www.forbes.com
September 16, 2026 at 4:19 PM
Memorial Sloan Kettering is opening up its voluminous data on genetic variants of cancer and their treatments with OpenEvidence
And OE also plans to use the data to develop a pipeline of therapies starting with a focus on rare cancers
NEW for @forbes.com
www.forbes.com/sites/innova...
And OE also plans to use the data to develop a pipeline of therapies starting with a focus on rare cancers
NEW for @forbes.com
www.forbes.com/sites/innova...
Reposted by Amy Feldman
Donald Trump is obsessed with the hot dogs at one of his golf courses. So obsessed that he orders one for everyone around him, including his Secret Service detail.
Then, according to a former employee, the club bills the Secret Service for the hot dogs.
www.forbes.com/sites/danale...
Then, according to a former employee, the club bills the Secret Service for the hot dogs.
www.forbes.com/sites/danale...
Hot-Dog Heaven: Inside Trump’s Golf Getaways
At his private golf clubs, the president barrels through foursomes, knocks away putts, and generally has the time of his life—with the government picking up the Secret Service’s hot-dog tab.
www.forbes.com
September 7, 2026 at 2:33 PM
Donald Trump is obsessed with the hot dogs at one of his golf courses. So obsessed that he orders one for everyone around him, including his Secret Service detail.
Then, according to a former employee, the club bills the Secret Service for the hot dogs.
www.forbes.com/sites/danale...
Then, according to a former employee, the club bills the Secret Service for the hot dogs.
www.forbes.com/sites/danale...
Before he was a Republican Senator, Roger Marshall was a doctor in Kentucky where he routinely charged 18% interest and sued 700 of his patients for unpaid debts 👀
www.nytimes.com/2026/09/08/u...
www.nytimes.com/2026/09/08/u...
Roger Marshall Sued 700 Patients for Debts; 81 Were Arrested. Now He’s a Senator.
Patients sued by Senator Roger Marshall of Kansas were routinely charged 18 percent interest, The Times found. Some had bank accounts garnished.
www.nytimes.com
September 9, 2026 at 5:50 PM
Before he was a Republican Senator, Roger Marshall was a doctor in Kentucky where he routinely charged 18% interest and sued 700 of his patients for unpaid debts 👀
www.nytimes.com/2026/09/08/u...
www.nytimes.com/2026/09/08/u...
In this week’s @forbes.com InnovationRx newsletter, I look at Inspiren, which uses sensors and AI to keep elderly residents of assisted living and memory care safer. It’s now raised another $70M led at $550M valuation to expand its predictive capabilities
www.forbes.com/sites/innova...
www.forbes.com/sites/innova...
The $550 Million Startup Bringing Sensors And AI To Senior Living Centers
Startup Inspiren is using AI and sensors to keep residents in assisted living and memory care healthier and out of the ER.
www.forbes.com
September 9, 2026 at 4:07 PM
In this week’s @forbes.com InnovationRx newsletter, I look at Inspiren, which uses sensors and AI to keep elderly residents of assisted living and memory care safer. It’s now raised another $70M led at $550M valuation to expand its predictive capabilities
www.forbes.com/sites/innova...
www.forbes.com/sites/innova...